Xilio Therapeutics, Inc. (XLO): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.54M
Year ended 2025-12-31
$1.32M
Trailing 12 months to 2026-09-30
-5.9%
3-year compound annual growth
+7.7%
5-year compound annual growth
$1.90M2020-12-31: $1.06M2021-12-31: $1.50M2022-12-31: $1.85M2023-12-31: $1.90M2024-12-31: $1.64M2025-12-31: $1.54M$1.54M
2020-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.54M-6.3%2026-03-23, From 2025-01-01
2024-12-31$1.64M-13.5%2026-03-23, From 2024-01-01
2023-12-31$1.90M+2.9%2025-03-11, From 2023-01-01
2022-12-31$1.85M+23.2%2024-04-01, From 2022-01-01
2021-12-31$1.50M+40.8%2023-03-02, From 2021-01-01
2020-12-31$1.06Mn/a2022-03-01, From 2020-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Xilio Therapeutics, Inc. (XLO)2025-12-31$1.54M-6.3%
Integrated Biopharma Inc (INBP)2026-06-30$293.0K-7.9%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$4.15M-15.4%
Aquestive Therapeutics, Inc. (AQST)2025-12-31$548.0K-23.7%
Biofrontera Inc. (BFRI)2025-12-31$138.0K-67.2%
Septerna, Inc. (SEPN)2025-12-31$1.60M+14.3%
Protagonist Therapeutics, Inc (PTGX)2025-12-31$1.28M+55.0%
Gossamer Bio, Inc. (GOSS)2025-12-31$24.0K-97.1%
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31$621.0K+16.3%

Compare XLO, INBP, CPIX, AQST side by side · Screen every company in Pharmaceutical Preparations ↗